|
|
-
BioSpecifics Technologies Posts Q1 EPS Of $0.19 Vs. $0.11 Last Year
5/10/2013
|
|
|
-
BioSpecifics Technologies Reports Positive Top-line Data From XIAFLEX® Phase IIa Study For Frozen Shoulder
3/26/2013
|
-
BioSpecifics Technologies Posts Q4 EPS Of $0.16 Vs. $0.01 Year Ago
3/12/2013
|
|
|
-
BioSpecifics Technologies Announces XIAFLEX Progress In Two Pipeline Indications
1/7/2013
|
-
BioSpecifics Technologies Announces Top-Line 30-Day Data From XIAFLEX Phase Ib Study For Treatment Of Cellulite
12/13/2012
|
|
|
-
BioSpecifics Technologies To Repurchase Up To $2 Mln Stock
11/15/2012
|